We report on 8 patients with giant lymph node hyperplasia (GLNH), diagnosed over a 10-year period. The age of the patients at diagnosis, the clinical presentation and the histological subtype varied, indicating that GNLH is a heterogeneous condition. One case was associated with liver cirrhosis, and in another patient bacterial endocarditis was diagnosed post mortem. Our study shows that GLNH is localized and benign in the young, and diffuse and aggressive in the elderly. It is concluded that GLNH should be separated into 3 clinical entities -namely, localized, systemic and reactive GLNH -defined by their clinical presentation and course, and correlated or not correlated with the histological findings.
Introduction
Giant lymph node hyperplasia (GLNH) was first described by Castleman et al. ' 2 in 1954 as a localized mass of mediastinal lymphoid follicles. Initially considered a benign disease, GLNH was later found to be associated with systemic manifestations,3 and 2 main pathological types have been defined: the hyaline vascular (HV) type, characterized by small hyalinized follicular centres and prominent interfollicular vascular proliferation, and the plasma cell (PC) type, characterized by an abundance of plasma cells.3 4 Intermediate or mixed types have also been described. 35 The PC type is typically associated with systemic symptoms such as fever, sweating, fatigue, anaemia, hyperglobulinaemia, and elevated erythrocyte sedimentation rate (ESR). The HV type usually presents as an asymptomatic localized disease, and affected lymph nodes form a localized mass in the mediastinum, neck, axilla or abdomen.
The nature and aetiology of GLNH remain unclear, and the relation between the morphological features and the clinical symptoms is not well defined. In an attempt to evaluate and correlate the pathological and clinical findings in GNLH, we report 8 cases, collected over a 10-year period.
Case reports (Table t Immunoglobulin electrophoresis showed elevation of kappa and delta chains in the IgG fraction. Antinuclear antibodies, antinuclear factor (ANF) and rheumatoid factor were negative. Liver-spleen scan revealed mild enlargement of the spleen. Bone marrow biopsy showed mild hypercellularity and a mild increase in the number of plasma cells.
The patient was discharged with the diagnosis of benign polyclonal gammopathy. Three months later he was noted to have huge masses of subaxillary and inguinal lymph nodes associated with peripheral oedema. The lymph nodes were 3 x 4 cm each and firm in consistency. At this stage the patient had normocytic, normochromic anaemia with haemoglobin 10 g/dl. Axillary biopsy disclosed GNLH of the HV and PC (mixed) type. Before treatment could be started, the patient died of probable pulmonary embolism. A 72 year old man with ischaemic heart disease, congestive heart failure, non-insulin-dependent diabetes mellitus and mild chronic renal failure was admitted because of anasarca and severe pruritus. Enlarged axillary and supraclavicular lymph nodes were detected. They were soft, measuring about 2 x 2 cm. Laboratory tests disclosed ESR of 96 mm/h and normal protein electrophoresis. Rheumatoid factor, ANF and antimitochondrial antibodies were negative. Chest X-rays revealed enlargement of the mediastinum, most likely due to enlarged lymph nodes. Axillary lymph node biopsy showed GLNH of the PC type ( Figure 1 ).
The patient died 3 months later, after a myocardial infarction.
Case 3
A 73 year old man with chronic ischaemic heart disease, chronic atrial fibrillation, papillary muscle dysfunction and congestive heart failure was admitted because of fever of unknown origin of two months' duration, accompanied by loss of weight and associated with vasculitis (eruptive purpura), generalized lymphadenopathy and hepatosplenomegaly. He was treated with prednisone for his vasculitis, with no effect on the lymphadenopathy.
Laboratory tests showed ESR of 100 mm/h, diffuse elevation of immunoglobulins, a positive test for rheumatoid factor at a dilution of 1:80, mixed IgG-IgM cryoglobulins, and antistreptolysin titre at a dilution of 1:2048. Bone marrow aspiration revealed a reactive marrow with 8% normal plasma cells.
The patient died 7 months later, and a postmortem examination revealed subacute streptococcal bacterial endocarditis. Examination of the lymph nodes showed GLNH of the PC type.
Case 4
A 47 year old woman was referred because of chest pain and dyspnoea. She was apyrexial, and no lymphadenopathy was observed. (Figure 2 ). Case 5 In an asymptomatic 15 year old boy, a mediastinal mass was noted on routine chest X-ray. He had no lymphadenopathy, and laboratory tests were normal. Thoracotomy revealed a mediastinal mass 4-5 cm in size and some enlarged mediastinal lymph nodes, 1 cm in size. Histological examination confirmed the diagnosis of GLNH, mixed type. Case 6 In an asymptomatic one and half year old girl, 4 connected lymph nodes, each about 0.5 cm in size and soft in consistency, were palpated. No hepatosplenomegaly was found. Blood tests were normal except for mild anaemia (haemoglobin: 10.6 g/dl). Histological examination of a lymph node biopsy demonstrated GLNH, mixed type.
Case 7
In an asymptomatic 1 year old girl with an enlarged left-sided supraclavicular lymph node, biopsy revealed GNLH ofthe HV type (Figure 3 ). Laboratory tests were normal. Five years later, lymphadenopathy of the left supraclavicular region had recurred. The child had remained asymptomatic, and the parents refused another biopsy. In an attempt to evaluate further and to correlate the pathological and clinical findings in GLNH, we collected and studied 8 cases (Table I) . In case 1, abnormal immunological manifestations such as elevated ESR, high levels of polyclonal immunoglobulins, and lymphocytosis in the bone marrow preceded the appearance of giant axillary lymph nodes by a period of at least 3 months, after which deterioration was rapid. The clinical presentation in case 1 is unique and serves to exemplify the concept that the histological featues in the lymph nodes are non-specific and reflect the effects of an ongoing immunological process.
In case 3, infective endocarditis was diagnosed post mortem, suggesting that GLNH of the PC type may have followed a period of bacteraemia and supporting the concept of 'reactive nonspecific changes'. Bacterial endocarditis can be added to the long list of diseases in which such pathological changes have been described. In case 8, GLNH of the PC type was associated with Budd-Chiari syndrome. Similar changes have been reported with chronic liver dysfunction and bile duct damage. '3 The clinical and morphological data collected in this study sdrve to confirm previous observations. The disease appears over a wide age range and is clinically heterogeneous. Our older patients (cases 1-3), males with a mean age of 75 years, had generalized lymphadenopathy associated with systemic clinical and laboratory manifestations. They had GLNH of either the PC type (cases 2 and 3) or the mixed type (case 1). Our young patients (cases 5-7) were asymptomaticand presented with a localized lesion confined to the mediastinal (case 7) or the supraclavicular region (cases 5 and 6). They had GLNH of either the HV type (case 7) or the mixed type (cases 5 and 6).
It seems that GLNH of the HV type is confined to the young age group and GLNH of the PC type to the old age group, while GLNH of the mixed type is distributed equally between the two groups. This trend has been observed by others, but is inconsistent with the hypothesis proposed by Keller et al.,4 namely that the PC variant represents an earlier more active stage of the pathological process and that the HV lesions appear at a later stage. The assumption that GLNH of the HV type occurs independently of an earlier PC type is further strengthened by recent reports documenting GLNH in early infancy. '4 The aetiology and pathogenesis of GLNH remain unclear. The morphological and clinical findings are not always well correlated. Lymph nodes from patients with GLNH of the PC type may be indistinguishable from lymph nodes from patients with acquired immune deficiency syndrome, Kaposi's sarcoma, rheumatoid arthritis, Wiskott-Aldrich syndrome, syphilis, lymphomas, and other disorders of immune regulation.5'101 '5-20 The association of GLNH with various systemic diseases such as myasthenia gravis, amyloidosis, temporal arteritis, jaundice and nephrotic syndrome has been reported.9' 1-3,17.21 The presence of humoral factors such as antierythropoietic, rheumatoid and lupus-like factors21 -24 is again suggestive of some immune dysregulation mechanism.
We conclude that GLNH should be separated into 3 clinical entities defined by the clinical presentation and course: (1) localized GLNH (cases 5-7), a hamartomatous benign lesion, usually confined to the young age group; (2) multicentric GLNH (cases 1 and 2), associated with generalized lymphadenopathy and systemic clinical and laboratory manifestations, usually confined to elderly male patients; and (3) reactive GLNH (cases 3 and 8), which is chronic and aggressive and associated with other systemic diseases. Such distinction is important in the choice of management. Localized GLNH is normally cured after excision of the tumour.4'22 Multicentric or systemic Castleman's disease behaves like a lymphoproliferative disorder, and the treatment of choice, whether steroids or antiblastic agents, remains to be identified. Altogether, the effects of treatment are difficult to evaluate in this group since these patients are old and usually die of unrelated causes.5'819 '23 
